Project Grant K99HG014205
Award Date 8/19/25
Completion Date 7/31/27
Dollars Obligated $178K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
- This $993,446 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) supports the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical cooperative programs of genes and genomic elements. The goal is to produce computational tools and workflows that can identify and rank functionally disease-critical...
- This $780,113 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to develop methods for quantifying and correcting biases in the genetic study of complex traits. Specifically, the research will: Create a comprehensive simulation framework to model realistic intergenerational dynamics and understand genetic transmission across generations. This will help correct biases in current methodologies used to study genetic architecture....
- This federal Project Grant award, titled "MULTIPLEXED LOCUS-SPECIFIC HYPERMUTATION FOR FUNCTIONAL CHARACTERIZATION OF THE CODING AND NONCODING GENOME", was provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to The Broad Institute, Inc. The $1,375,594 award will fund the development of a novel platform called "Helicase-Assisted Continuous Evolution (HACE)" that can perform targeted, high-throughput mutagenesis within the mammalian...
- The National Human Genome Research Institute (NHGRI) awarded a $1,711,422 Project Grant (CFDA 93.172 - Human Genome Research) to the New York Genome Center, Inc. (NYGC) on September 23, 2024. The goal of this project is to develop a suite of privacy-preserving tools for transcriptomic data analysis, including methods for quantifying bulk and single-cell gene expression, as well as performing expression quantitative trait locus (eQTL) mapping on encrypted genotypes. This will enable large-scale...
- This federal Project Grant award, provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research), supports the development of innovative computational and statistical methods for conducting genome-wide association studies (GWAS) on time-to-event (TTE) phenotypes in large biobanks and cohorts. The $3,287,168 award, granted on September 17, 2025, aims to overcome current limitations in GWAS of TTE phenotypes by developing scalable methods for rare variant...
- This $362,340 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to identify genes that shape complex multigenic traits within and between yeast species. The objectives are to apply a new genetic mapping method called CRI-SPA-MAP to discover causal genes that influence the ability of yeast strains to grow in diverse environmental conditions. The research will be conducted at the University of Minnesota from August 2025 to...
- The National Human Genome Research Institute (NHGRI) awarded a $457,920 Project Grant (CFDA #93.172 - Human Genome Research) to The Broad Institute, Inc. to develop a deep reinforcement learning framework for haplotype assembly. Haplotype assembly is critical for understanding human population genetics and disease, as it reconstructs the combination of alleles on maternally and paternally inherited chromosome copies. The Broad Institute, a renowned biomedical and genomic research organization,...
- This $400,000 Project Grant award from the National Human Genome Research Institute (NHGRI) under CFDA 93.172 "Human Genome Research" will support a research program at Brigham & Women's Hospital to develop advanced computational methods for accurately identifying and genotyping structural variants within large genetic biobank datasets. The key objectives of the work are to: 1) create haplotype-informed algorithms to improve detection sensitivity and genotyping accuracy for...
- This federal Project Grant award of $133,332 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research by the Massachusetts Institute of Technology (MIT) to develop a measurement system that will quantify the kinetic parameters controlling translation initiation across the human transcriptome. The goal is to better understand the protein-coding capacity of the human genome and how initiation rates vary across cell types. This 5-year research...
- This federal Project Grant award of $1,350,896, awarded on January 1, 2025 by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), supports the development of a multimodal massively parallel reporter assay (MPRA) platform to study regulatory sequence function. The overarching goal is to create tools that can elucidate the mechanisms and grammar by which regulatory elements in the genome encode interactions between chromatin, regulatory...
This $178,416 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research by the Whitehead Institute for Biomedical Research to explore the concept of "transcriptional adaptation" - a novel mechanism by which cells can compensate for certain genetic mutations. Key objectives include characterizing the molecular properties of "trigger RNAs" that can induce transcriptional adaptation, as well as investigating how this adaptation process broadly influences the landscape of genetic diseases. The research aims to advance the understanding of genetic robustness and develop potential gene-augmenting therapeutic applications. This 2-year award runs from August 2025 to July 2027.
Generated 10/21/25, 6:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $178.4k | 8/18/25 |